Parental epilepsy, anticonvulsant drugs, and reproductive outcome: Epidemiologic and experimental findings spanning three decades; 1: Animal studies
- 31 December 1991
- journal article
- review article
- Published by Elsevier in Reproductive Toxicology
- Vol. 5 (4) , 281-299
- https://doi.org/10.1016/0890-6238(91)90090-3
Abstract
No abstract availableKeywords
This publication has 89 references indexed in Scilit:
- Genetic Differences in Susceptibility to Anticonvulsant Drug‐Induced Developmental DefectsBasic & Clinical Pharmacology & Toxicology, 1991
- Teratogenic effects on the neuroepithelium of the CD‐1 mouse embryo exposed in utero to sodium valproateTeratology, 1990
- Verification of the fetal valproate syndrome phenotypeAmerican Journal of Medical Genetics, 1988
- Valproic acidTeratology, 1987
- Species differences in pharmacokinetics and drug teratogenesis.Environmental Health Perspectives, 1986
- Fetal growth, major malformations, and minor anomalies in infants born to women receiving valproic acidThe Journal of Pediatrics, 1986
- The fetal valproate syndromeAmerican Journal of Medical Genetics, 1984
- Maternal phenytoin administration affects DNA and protein synthesis in embryonic primary palatesTeratology, 1983
- Effect of phenytoin on maternal heart rate in A/J mice: Possible role in teratogenesisTeratology, 1983
- Phenytoin (dilantin)‐induced cleft lip and palate in a/j mice: A scanning and transmission electron microscopic studyThe Anatomical Record, 1979